MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) has announced the completion and delivery of its first Edge AI Intoxication and Fatigue Detection Kiosk prototypes, marking a significant step in the commercialization of voice-based impairment detection technology for workplace safety. The kiosks leverage artificial intelligence to analyze short voice samples for over 140 acoustic markers associated with potential impairment from alcohol, drugs, or fatigue, with models trained on more than 50 million data points, according to a press release.
The prototypes are now entering testing, validation, and data-analysis phases involving industry participants, speech specialists, and software engineers as the company refines its predictive models and assesses real-world performance. MindBio is targeting safety-sensitive industries including mining, aviation, construction, transportation, and law enforcement, where large workforces and operational risks make conventional testing methods—such as breath, saliva, urine, and laboratory tests—costly and time-consuming.
The company’s approach is designed to provide rapid, scalable, and less invasive initial screening. Individuals flagged for potential impairment can then undergo additional evaluation using established testing protocols. This could significantly streamline safety checks in high-risk environments, potentially reducing accidents and improving compliance.
The implications of this technology are far-reaching. For industries like mining and construction, where impairment can lead to catastrophic incidents, a quick and non-invasive screening tool could enhance safety without disrupting workflows. For employers, it offers a cost-effective alternative to traditional testing, which often requires specialized equipment and trained personnel. Moreover, the AI-driven system’s ability to detect fatigue—a common but under-screened risk—adds a new dimension to workplace safety programs.
MindBio’s Edge AI kiosks are part of a broader enterprise platform that integrates bespoke hardware and software for detecting drug and alcohol intoxication using voice analysis. The company’s AI prediction model, built on over 50 million data points, aims to predict alcohol intoxication with high accuracy solely from voice samples. This technology could potentially be adapted for other applications, such as roadside sobriety checks or remote workforce monitoring.
For more information, visit the company’s website at www.MindBioTherapeutics.com. The latest news and updates relating to MBQIF are available in the company’s newsroom at https://ibn.fm/MBQIF.
